This Miami-based organization operates as a research and manufacturing company focused on biologic materials used in regenerative medicine, supporting investigational, research, and regulated clinical applications. It works within established quality systems and applicable regulatory frameworks, collaborating with healthcare providers, researchers, and institutions.
The company's work centers on exosome-based biologics. Its leadership includes a Chief Medical Officer who has practiced medicine for over 30 years and serves as a principal investigator on multiple FDA-approved exosome trials. Strategic partners referenced include academic and healthcare institutions such as Baptist Health, Hospital for Special Surgery, NYU Langone, and Mount Sinai.
Leadership combines expertise in corporate strategy, clinical medicine, and biologics manufacturing, with a stated emphasis on responsible advancement, consistency, transparency, and manufacturing rigor within the evolving field of regenerative medicine.
We link out to Google's real reviews rather than reproducing review text here.